Researchers at the University of Toledo have developed a rapid blood assay that detects elevated bile acids—an early marker of liver disease—by measuring red blood cell membrane rigidity.
Researchers developed a quick clinical test that predicts which people with neck pain are likely to benefit from epidural steroid injections.
Researchers have built a new, easy-to-use test that could diagnose non-infectious diseases like heart attacks and cancers more quickly.
The Center of BioModular Multi-Scale Systems for Precision Medicine creates rapid tests for human ailments like cancer, stroke, and COVID.
Read More
A new study suggests continuous assessment and updating is likely needed in the context of variants of concern for rapid antigen COVID tests.
Read More
Beckman Coulter’s new antipsychotic drug aims to address an unmet clinical need for 69 million people with serious mental conditions.
Read More
The FDA has granted Pathogenomix with a Breakthrough Device Designation for its Patho-Seq assay due to its methodologies of pathogenic bacteria diagnosis.
Read More
GS Labs rapid antigen tests also had a 26% positivity rate, up from 22% the previous week and was only 8% during Thanksgiving week.
Read More
A study that screened asymptomatic workers for SARS-CoV-2 via rapid tests showed the rate of false-positive results among the total screens was very low.Â
Read More
Meridian Bioscience says its Curian Campy assay—an immunoassay for the detection of a Campylobacter-specific antigen—received FDA clearance. Â
Read More
A portable and rapid prostate cancer screening kit could provide early warning to populations with higher incidence of prostate cancer.
Read More
The FDA alerted that false reactivity Rapid Plasma Reagin test results in a Bio-Rad RPR kit can occur for some who received a COVID-19 vaccine.
Read More
LumiraDx’s SARS-CoV-2 assay will now offer a self-collected COVID-19 nasal specimen collection kit through a new partnership with Audere.
Read More
A new study found COVID-19 rapid antigen detection tests proved more effective than expected when compared to the polymerase chain reaction (PCR) assay.
Read More
The LumiraDx SARS-CoV-2 RNA STAR Complete has been authorized by FDA for emergency use under an EUA for use by authorized laboratories.Â
Read More
The Maverick line of qPCR instruments from Anitoa Systems has received U.S. FDA registration and device listing as class II 510(k) exempt medical devices.
Read More
While welcoming a renewed emphasis on testing, some healthcare leaders warn that America’s path forward requires balancing testing speed with accuracy.
Read More
Rockefeller University’s “DRUL” saliva test performs as well as, if not better, than FDA-authorized nasal and oral swab tests.
Read More